Biogen Inc. is a pharmaceutical company.
Biogen Inc. (BIIB) is expected to report earnings on Wednesday, October 28, 2026, before the open. Estimated release time 06:43 ET. Consensus EPS estimate is $2.02.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-29 | Jun 2026 qtr | $2.94 | $3.60 | — | $2.74B |
| 2026-04-29 | Mar 2026 qtr | $3.05 | $3.57 | — | $2.48B |
| 2026-02-06 | Dec 2025 qtr | $1.63 | $1.99 | — | $2.28B |
| 2025-10-30 | Sep 2025 qtr | $3.88 | $4.81 | — | $2.45B |
| 2025-07-31 | Jun 2025 qtr | $3.90 | $5.47 | — | $2.65B |
| 2025-05-01 | Mar 2025 qtr | $2.90 | $3.02 | +4.1% | $2.43B |
| 2025-02-12 | Dec 2024 qtr | $3.43 | $3.44 | +0.3% | $2.45B |
| 2024-10-30 | Sep 2024 qtr | $3.77 | $4.08 | +8.2% | $2.47B |
BIIB has beaten consensus EPS in 3 of its last 3 scored quarters.
See BIIB on the live calendar →